Evidence map›Paper›PMID 37101031›Full record

ArticleWiener klinische Wochenschrift2023

[Diabetes mellitus in childhood and adolescence (Update 2023)].

Birgit Rami-Merhar, Elke Fröhlich-Reiterer, Sabine E Hofer, Maria Fritsch

Open access · hybridAbstract readEnglish Abstract
In one paragraph

Article in Wiener klinische Wochenschrift, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Birgit Rami-MerharUniversitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich. birgit.rami@meduniwien.ac.at.
Elke Fröhlich-ReitererUniversitätsklinik für Kinder- und Jugendheilkunde, Abteilung für allgemeine Pädiatrie, Medizinische Universität Graz, Graz, Österreich.
Sabine E HoferUniversitätsklinik für Kinder- und Jugendheilkunde, Department für Pädiatrie, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Maria FritschUniversitätsklinik für Kinder- und Jugendheilkunde, Abteilung für allgemeine Pädiatrie, Medizinische Universität Graz, Graz, Österreich.
Medical University of Graz · ATInnsbruck Medical University · ATMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In contrast to adults, type 1 diabetes mellitus (T1D) is the most frequent form of diabetes in childhood and adolescence (> 90%). After diagnosis the management of children and adolescents with T1D should take place in highly specialized pediatric units experienced in pediatric diabetology. The lifelong substitution of insulin is the cornerstone of treatment whereby modalities need to be individually adapted for patient age and the family routine. In this age group the usage of diabetes technology (glucose sensors, insulinpumps and recently hybrid-closed-loop-systems) is recommended. An optimal metabolic control right from the start of therapy is associated with an improved long-term prognosis. Diabetes education is essential in the management of patients with diabetes and their families and needs to be performed by a multidisciplinary team consisting of a pediatric diabetologists, diabetes educator, dietitian, psychologist and social worker. The Austrian working group for pediatric endocrinology and diabetes (APEDÖ) and the ISPAD (International Society for Pediatric and Adolescent Diabetes) recommend a metabolic goal of HbA1c ≤ 7.0%, ((IFCC) < 53 mmol/mol), and a "Time in range" > 70% for all pediatric age groups without the presence of severe hypoglycemia. Age-related physical, cognitive and psychosocial development, screening for associated diseases, avoidance of acute diabetes-related complications (severe hypoglycemia, diabetic ketoacidosis) and prevention of diabetes-related late complications to ensure high quality of life are the main goals of diabetes treatment in all pediatric age groups.

Indexed as

Diabetes Mellitus, Type 1HypoglycemiaAdolescentBlood GlucoseChildGlycated HemoglobinHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsQuality of LifeBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinInsulin pump treatmentMetabolic controlSevere hypoglycemic eventsType 1 diabetes

Identifiers

PMID37101031
PMCPMC10132915
OpenAlexW4367147318

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.